Find Mazdutide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

0

FDA Orange Book

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ibi362, Glxc-26803, 2259884-03-0
Molecular Formula
C207H317N45O65
Molecular Weight
4476  g/mol
InChI Key
XRBYWQZGSZWYEJ-HMQIFOERSA-N

Mazdutide
1 2D Structure

Mazdutide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
20-[[(1S)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-2-methylpropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]hexanoyl]amino]propanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[2-[(2S)-2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-20-oxoicosanoic acid
2.1.2 InChI
InChI=1S/C207H317N45O65/c1-116(2)93-144(189(295)230-138(70-76-168(271)272)179(285)221-107-162(264)219-109-166(268)252-86-46-57-157(252)201(307)245-154(110-253)181(287)220-106-159(213)261)234-190(296)145(94-117(3)4)236-194(300)151(100-127-104-218-133-52-37-36-51-131(127)133)240-188(294)142(73-79-171(277)278)233-202(308)174(119(7)8)249-197(303)149(96-123-47-30-28-31-48-123)238-187(293)141(72-78-170(275)276)231-183(289)135(56-41-45-83-215-164(266)113-316-91-90-315-88-85-217-165(267)114-317-92-89-314-87-84-216-160(262)75-69-143(205(311)312)225-161(263)58-34-26-24-22-20-18-16-14-15-17-19-21-23-25-27-35-59-167(269)270)226-177(283)120(9)224-182(288)134(53-38-42-80-208)227-184(290)136(54-39-43-81-209)228-186(292)140(71-77-169(273)274)232-195(301)152(102-172(279)280)241-191(297)146(95-118(5)6)235-192(298)147(98-125-60-64-129(258)65-61-125)237-185(291)137(55-40-44-82-210)229-199(305)155(111-254)244-193(299)148(99-126-62-66-130(259)67-63-126)239-196(302)153(103-173(281)282)242-200(306)156(112-255)246-204(310)176(122(11)257)250-198(304)150(97-124-49-32-29-33-50-124)243-203(309)175(121(10)256)248-163(265)108-222-180(286)139(68-74-158(212)260)247-206(313)207(12,13)251-178(284)132(211)101-128-105-214-115-223-128/h28-33,36-37,47-52,60-67,104-105,115-122,132,134-157,174-176,218,253-259H,14-27,34-35,38-46,53-59,68-103,106-114,208-211H2,1-13H3,(H2,212,260)(H2,213,261)(H,214,223)(H,215,266)(H,216,262)(H,217,267)(H,219,264)(H,220,287)(H,221,285)(H,222,286)(H,224,288)(H,225,263)(H,226,283)(H,227,290)(H,228,292)(H,229,305)(H,230,295)(H,231,289)(H,232,301)(H,233,308)(H,234,296)(H,235,298)(H,236,300)(H,237,291)(H,238,293)(H,239,302)(H,240,294)(H,241,297)(H,242,306)(H,243,309)(H,244,299)(H,245,307)(H,246,310)(H,247,313)(H,248,265)(H,249,303)(H,250,304)(H,251,284)(H,269,270)(H,271,272)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,311,312)/t120-,121+,122+,132-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,174-,175-,176-/m0/s1
2.1.3 InChI Key
XRBYWQZGSZWYEJ-HMQIFOERSA-N
2.1.4 Canonical SMILES
CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NCC(=O)NCC(=O)N1CCCC1C(=O)NC(CO)C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(CC8=CNC=N8)N
2.1.5 Isomeric SMILES
C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N7CCC[C@H]7C(=O)N[C@@H](CO)C(=O)NCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)C(C)(C)NC(=O)[C@H](CC8=CNC=N8)N)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Ibi362

2. Ly3305677

2.2.2 Depositor-Supplied Synonyms

1. Ibi362

2. Glxc-26803

3. 2259884-03-0

2.3 Create Date
2023-03-27
3 Chemical and Physical Properties
Molecular Weight 4476 g/mol
Molecular Formula C207H317N45O65
XLogP3-12.6
Hydrogen Bond Donor Count58
Hydrogen Bond Acceptor Count70
Rotatable Bond Count164
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area1750
Heavy Atom Count317
Formal Charge0
Complexity10500
Isotope Atom Count0
Defined Atom Stereocenter Count31
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more

01

Fujian Genohope Biotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFujian Genohope Biotech is a leading provider of high-potency peptide APIs, offering GMP quality and worldwide delivery.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

02

ApiSyn

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothApiSyn: From early-phase research and process development to reliable cGMP manufacturing worldwide.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

03

Guizhou Utide Biotechnology Co., L...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGuizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

04

Shenzhen JYMed Technology

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BePharma
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFujian Genohope Biotech is a leading provider of high-potency peptide APIs, offering GMP quality and worldwide delivery.

Flag China
Digital Content Digital Content

Mazdutide

About the Company : Fujian Genohope Biotech Ltd, established in 2019, specializes in high-potency polypeptide APIs and provides global API and preparation manufacturing services. Co-founded by New Hop...

Fujian Genohope Biotech Ltd, established in 2019, specializes in high-potency polypeptide APIs and provides global API and preparation manufacturing services. Co-founded by New Hope Hosencare Brothers and Taiwan Genovior Biotech Corporation, the company operates from the Cross-Strait Biotechnology and Health and Medical Industry Cooperation Zone in Fujian, China. With a 70,000-square-meter GMP-compliant facility and 11 production lines, it meets regulatory requirements for China, the U.S., and international markets. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

02

ApiSyn

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothApiSyn: From early-phase research and process development to reliable cGMP manufacturing worldwide.

Flag India
Digital Content Digital Content

Mazdutide

About the Company : ApiSyn Healthcare, established in 2017, is a vertically integrated manufacturer of APIs & intermediates serving the global pharmaceutical industry. As part of SynZeal Research, a p...

ApiSyn Healthcare, established in 2017, is a vertically integrated manufacturer of APIs & intermediates serving the global pharmaceutical industry. As part of SynZeal Research, a privately owned organization founded in 2011, ApiSyn is driven by innovation & strong R&D capabilities. Supported by an experienced workforce, the company offers end-to-end CDMO services including synthesis and development, early-phase studies, custom synthesis, and cGMP manufacturing, delivering high-quality and flexible chemistry solutions worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGuizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

Flag China
Digital Content Digital Content

Mazdutide

About the Company : Guizhou Utide Biotechnology Co., Ltd., based in Zunyi, Guizhou, is a specialized manufacturer of GLP-1 peptide APIs with 20,000 m² of manufacturing facilities. Backed by a core te...

Guizhou Utide Biotechnology Co., Ltd., based in Zunyi, Guizhou, is a specialized manufacturer of GLP-1 peptide APIs with 20,000 m² of manufacturing facilities. Backed by a core team with 20+ years of peptide R&D and GMP experience, we excel in route development, process optimization, and rapid scale-up. Phase I & II facilities are operational, with Phase III GMP expansion planned. U.S. DMFs obtained for tirzepatide (042984) and retatrutide (043330), with global filings underway. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

04

ChemTides
Not Confirmed
arrow
arrow
ChemTides
Not Confirmed

Mazdutide

About the Company : Shenzhen JYMed Technology Co.,Ltd is a high-tech enterprise engaged in research and development, manufacturing and commercialization of peptides based products, including active ph...

Shenzhen JYMed Technology Co.,Ltd is a high-tech enterprise engaged in research and development, manufacturing and commercialization of peptides based products, including active pharmaceutical ingredient peptides, cosmetic peptides, and custom peptides as well other new drug development. We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis. Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Partnership expands across oncology and immunology, strengthening Lilly’s next-generation pipeline. Innovent will lead programs from discovery through Phase II trials in China; Lilly gains exclusive rights outside Greater China.


Lead Product(s): Mazdutide,Inapplicable

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: DiscoveryProduct Type: Antibody, Unconjugated

Sponsor: Eli Lilly

Deal Size: $8,850.0 million Upfront Cash: $350.0 million

Deal Type: Collaboration February 09, 2026

blank

01

BePharma
Not Confirmed
BePharma
Not Confirmed

Details : Partnership expands across oncology and immunology, strengthening Lilly’s next-generation pipeline. Innovent will lead programs from discovery through Phase II trials in China; Lilly gains exclusive rights outside Greater China.

Product Name : Undisclosed

Product Type : Antibody, Unconjugated

Upfront Cash : $350.0 million

February 09, 2026

blank

Details:

Mazdutide is a peptide candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Obesity.


Lead Product(s): Mazdutide,Inapplicable

Therapeutic Area: Nutrition and Weight Loss Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 28, 2025

blank

02

BePharma
Not Confirmed
BePharma
Not Confirmed

Details : Mazdutide is a peptide candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Obesity.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

November 28, 2025

blank

Details:

IBI362 (mazdutide) is a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, approved for glycemic control in adults with type 2 diabetes (T2D).


Lead Product(s): Mazdutide,Inapplicable

Therapeutic Area: Endocrinology Brand Name: IBI362

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 19, 2025

blank

03

BePharma
Not Confirmed
BePharma
Not Confirmed

Details : IBI362 (mazdutide) is a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, approved for glycemic control in adults with type 2 diabetes (T2D).

Product Name : IBI362

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

September 19, 2025

blank

Details:

IBI-362 (mazdutide) is the world's first dual GCG/GLP-1 receptor agonist. It is being indicated for chronic weight management in Chinese adults with overweight or obesity.


Lead Product(s): Mazdutide,Inapplicable

Therapeutic Area: Nutrition and Weight Loss Brand Name: IBI-362

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 26, 2025

blank

04

BePharma
Not Confirmed
BePharma
Not Confirmed

Details : IBI-362 (mazdutide) is the world's first dual GCG/GLP-1 receptor agonist. It is being indicated for chronic weight management in Chinese adults with overweight or obesity.

Product Name : IBI-362

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

June 26, 2025

blank

Details:

IBI362 is a Peptide drug candidate, which is currently being evaluated in Phase I/ Phase II clinical studies for the treatment of Obesity.


Lead Product(s): Mazdutide,Inapplicable

Therapeutic Area: Nutrition and Weight Loss Brand Name: Undisclosed

Study Phase: Phase I/ Phase IIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 03, 2025

blank

05

BePharma
Not Confirmed
BePharma
Not Confirmed

Details : IBI362 is a Peptide drug candidate, which is currently being evaluated in Phase I/ Phase II clinical studies for the treatment of Obesity.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

June 03, 2025

blank

Details:

IBI362 (mazdutide) is a glucagon-like peptide-1 receptor GLP-1R/GCGR dual agonist. It is being evaluated in patients with obesity accompanied fatty liver disease.


Lead Product(s): Mazdutide,Inapplicable

Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 15, 2025

blank

06

BePharma
Not Confirmed
BePharma
Not Confirmed

Details : IBI362 (mazdutide) is a glucagon-like peptide-1 receptor GLP-1R/GCGR dual agonist. It is being evaluated in patients with obesity accompanied fatty liver disease.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

May 15, 2025

blank

Details:

IBI362 is a Peptide drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Non-alcoholic Fatty Liver Disease.


Lead Product(s): Mazdutide,Inapplicable

Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 22, 2025

blank

07

BePharma
Not Confirmed
BePharma
Not Confirmed

Details : IBI362 is a Peptide drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Non-alcoholic Fatty Liver Disease.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

April 22, 2025

blank

Details:

IBI362 is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Sleep Apnea Syndromes.


Lead Product(s): Mazdutide,Inapplicable

Therapeutic Area: Sleep Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 16, 2025

blank

08

BePharma
Not Confirmed
BePharma
Not Confirmed

Lead Product(s) : Mazdutide,Inapplicable

Therapeutic Area : Sleep

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : IBI362 is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Sleep Apnea Syndromes.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

April 16, 2025

blank

Details:

IBI362 is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Overweight.


Lead Product(s): Mazdutide,Inapplicable

Therapeutic Area: Nutrition and Weight Loss Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 19, 2025

blank

09

BePharma
Not Confirmed
BePharma
Not Confirmed

Details : IBI362 is a Peptide drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Overweight.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

March 19, 2025

blank

Details:

IBI362 is a Peptide drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Obesity.


Lead Product(s): Mazdutide,Inapplicable

Therapeutic Area: Nutrition and Weight Loss Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 06, 2025

blank

10

BePharma
Not Confirmed
BePharma
Not Confirmed

Details : IBI362 is a Peptide drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Obesity.

Product Name : Undisclosed

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

March 06, 2025

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Looking for / Mazdutide API manufacturers, exporters & distributors?

Mazdutide manufacturers, exporters & distributors 1

93

PharmaCompass offers a list of Mazdutide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mazdutide manufacturer or Mazdutide supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mazdutide manufacturer or Mazdutide supplier.

PharmaCompass also assists you with knowing the Mazdutide API Price utilized in the formulation of products. Mazdutide API Price is not always fixed or binding as the Mazdutide Price is obtained through a variety of data sources. The Mazdutide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Mazdutide

Synonyms

Ibi362, Glxc-26803, 2259884-03-0

Mazdutide Manufacturers

A Mazdutide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mazdutide, including repackagers and relabelers. The FDA regulates Mazdutide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mazdutide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Mazdutide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Mazdutide Suppliers

A Mazdutide supplier is an individual or a company that provides Mazdutide active pharmaceutical ingredient (API) or Mazdutide finished formulations upon request. The Mazdutide suppliers may include Mazdutide API manufacturers, exporters, distributors and traders.

click here to find a list of Mazdutide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Mazdutide GMP

Mazdutide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Mazdutide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mazdutide GMP manufacturer or Mazdutide GMP API supplier for your needs.

Mazdutide CoA

A Mazdutide CoA (Certificate of Analysis) is a formal document that attests to Mazdutide's compliance with Mazdutide specifications and serves as a tool for batch-level quality control.

Mazdutide CoA mostly includes findings from lab analyses of a specific batch. For each Mazdutide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Mazdutide may be tested according to a variety of international standards, such as European Pharmacopoeia (Mazdutide EP), Mazdutide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mazdutide USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty